Member Info for TopCatz

So why are they expecting FDA approval in H2?
------------------------------------------------------------
Nobody here can help you with that Steve but I expect they will be working closely with the FDA on this. We can only wait and see. Just can't see Clifford coming out with a comment like that if a delay RNS is imminent. (that's not to say it's impossible of course)

Nothing to do but let it unfold

I think they will sell Belluscura once they list on the market, or at least they will if they have any sense

Explains the drift in share price. Someone always knows and it's always the way. It's such a tiny market cap that 380,000 is palatable.

Very much like the news on Belluscura. Max would not invite an eggy face if he knew it was a dead duck so that's positive. Also the comments regarding Salarius and Mexico which looks like it's where they have the best chance of scoring for now and Guident. Those regenerative shock absorbers are going to make them by the sound of it and we know how huge the electric car market is in comparison to AV.

Lastly, it's pretty routine for good news to flow after placements. It's probably been on the cards for months and the lenders probably call the shots to a degree on how much they want to pay so always get in low on the cycle.

Overall good to get this out the way and now for progress and good news flow over the coming weeks/months

Thanks for the update CM - Good info. That product is good so essential they get it to market quick. I expect they will RNS the launch

Valid points Cheeks.

Victor looked pretty smug in his last update and suggested that although the saltme were proof of concept that they were selling really well. Add to that the major North American and Mexican ingredients distributors they've recently signed up with and you would expect some headway. As you say an update on sales figures even at this preliminary stage would be handy.

Lucyd have also just launched their aesthetically pleasing new product so hopefully they will be shifting those too. Can't speak much about the spec (no pun intented) but it appears to be well received.

So early revenue on both fronts and Belluscura dragging it's heals.

I imagine there will be some sort of update relatively soon so let's hope there s some good news in there.

Means a lot of wonga is getting moved about. Big boys only but us minnows just have to hold tight. This is on the turn for sure

Well knock me down with a feather ........ we’re blue !!!
-----------------------------------------------------
Shorts have hit their target. Everyone will be loading up for the next ride now :)

Good to see LUCYD mixing it up with the industry leaders. Should be on sale around now and they may have finally got this right. Hopefully some revenue on stream now - SP could do with a lift !

https://twitter.com/tekcapital/status/1325959993355608064

I hope they haven't ordered a load of Dora the x -plorer kids rucksacks by mistake

-----------------------------------------------------------------------------------------------------------

If they can turn them over for a profit I'm in - Actually I'm in anyway !

Morning Steve

I think we can assume the units are here. They arrived in June and the FDA are aware (it's their report) so we know everything is in motion (slow by the looks of it) I have no idea where they are with it now, or what is involved, or if there are logistics that need tying up so they can get clearance, list etc seamlessly. Anyone directly invested in Belluscura may be able to help us out with the dots and the t's

https://fda.report/Company/Belluscura

Totally agree on the necessity for an update BB although good to see these units arrived. My guess is not in time for whatever they had to do to get Approval through. Hopefully not too far away - Belluscura website states the anticipated sale of x-plor is H1 2021 so realistically they would need approval this year.

Best

HI Big Bang. That's what I though initially but check the weight in the 'sub' - Infers the whole unit and associated packaging but i'm guessing as we all are !

The following Bill of Lading record outlines a container shipment imported into the US by BELLUSCURA. This shipment is registered as coming from FOSHAN NANHAI WORLD RICHMAN TECHNOL via Yantian,China (Mainland). Manifest records show a quanitity of 29 CTN with a total weight of 150 Kilograms arrived on 2020-06-03 via the vessel COSCO SHIPPING DENALI to the port of Long Beach, California. Cargo includes products identified as x-plor backpack x-plor carry bag hs code:4202129000

It looks like it relates to a shipment from China in June. Maybe this is something to do with the supply chain problem on the run up to the last delay. Hard to fathom but at least we can see something has been going on

https://fda.report/Company/Belluscura

I can't work this out but haven't found this on the net before so wondering if it s current and the 29 relates to units. Probably barking up the wrong tree and it's probably a register from earlier in the year. Says 2020 for website so we know it's this year but can't find specific dates. Out today but if anyone can make head or tail !

It's probably a missed deadline but that's not entirely surprising due to the complexity of launching all this. The fact they haven't RNS'd the delay yet probably indicates a conclusion is not far off and they're taking it to the wire.

Still think they'll miss it and there will be an RNS tomorrow or Monday stating delay. Not a massive problem in the great scheme of things.

Strong support here on the fibs from original rise.

Agreed Adamsky

I think before the end of the year TEK should put out a comprehensive update on all 5 companies in their portfolio and break down revenues between the companies. We know Salarius and Lucyd will produce some sort of revenue (small at this stage) but it would be nice to get a bigger picture as they hopefully scale up

Patents whilst not going to make an immediate impact will increase the odds on LUCYD being taken out by one of it's competitors imo so not totally without value.

Thanks for posting Pen

Great interview and I think anyone invested here should listen to all of this. Tania was asking all the right questions imo.

1. Salt me as we assumed is 'proof of concept only' and non core business, however in his own words is a success as it's filling a market niche that hardly exists and has wide gross (or growth, I didn't quite catch it) margins. Good to hear that they are selling and making something at least with this.

2. The testing/sell cycle is typically 3 to 6 months, testing and then changing manufacturers packagind, advertising etc to introduce. There has been some impact because of Covid.

3. Asked directly if Salarius are likely to land a 'big player' which is what we all want to hear he sounded extremely optimistic. He said there are several (4-5) that are currently testing. You will have to listen yourselves but it sounds like something might drop in the non too distant. We know what that will do to the SP.

4. They are concentrating on America and Mexico now but he predicts by the end of 2021, beginning of 2022 they will be winning global contracts, in particular other South American countries but there is also interest in Asia.

5. Asked if there would be any problem scaling up he confidently says 'no' which is also good to hear.

All in all that's about as good as we can expect. Settled my nerves. Interested to hear what others think too

Very oversold now and should be due a decent bounce soon. It really doesn't take much to move it either way. Great on a buying day of course but not much fun on a down day :(

Actually that's not the case. Got mixed up with LUCYD !